Dr Suranjith Seneviratne

MBBS, MD, FRCP, FRCPath, DPhil (Oxon), FCCP

Specialities
Allergy Medicine, Immunology
Year of first qualification
1992
GMC Number
6032936
Telephone
07508 976860 (Secretary)
Fax
01865 778864
Email

Suranjith completed his basic Medical Degree with First Class Honours, eight distinctions and ten Gold medals and was placed first in his year. He completed his MD in Internal Medicine and trained in Clinical Immunology and Allergy at the John Radcliffe Hospital in Oxford. He completed a DPhil in Molecular Immunology and Allergy at the Weatherall Institute of Molecular Medicine, University of Oxford as a Commonwealth Scholar.

He is currently a Consultant in Clinical Immunology and Allergy at the Royal Free Hospital and University College London. The UCL Centre for Immunodeficiency, Royal Free Hospital, is the largest Primary Immunodeficiency Centre in Europe. Prior to that, he was Consultant and Lead Clinician in Clinical Immunology and Allergy at St Mary’s Hospital and Imperial College London, a world renowned Allergy and Immunology Centre, and the birth place of the widely practiced procedure of Allergen Immunotherapy over 100 years ago.

Professor Seneviratne is Director of the Centre for Mast Cell Disorders and the President of the UK-Sri Lanka Immunology Foundation, an organisation that contributes to Immunology and Allergy education in Sri Lanka.


Clinics

  • By arrangement

Locations

Current posts

  • Consultant in Clinical Immunology &amp
  • Allergy, Royal Free Hospital, London, UK
  • Consultant in Clinical Immunology &amp
  • Allergy, Centre for Immunodeficiency, University College London, London, UK.

Member of

  • Royal College of Physicians
  • Royal College of Pathologists
  • British Society of Immunology
  • British Society of Allergy &amp
  • Clinical Immunology
  • European Academy of Allergy & Clinical Immunology
  • American Academy of Allergy & Clinical Immunology
  • Clinical Immunology Society
  • European Society of Immunodeficiency

Research

Professor Seneviratne has authored 132 journal publications and was one of the UK principal investigators in the recently completed Pan-European adult Food Allergy study (EUROPREVALL).

He is currently the Principal Investigator of the STILLPAD-UK study, a prospective study of lung disease in Immunodeficiency.

He is a member of the NIHR Bio-resource Genetic study on Primary Immunodeficiency patients and is involved in several molecular genetic studies on patients with Hyper IgM syndrome, LRBA deficiency, Hyper IgE syndrome, CVID, Complement deficiencies, Food Allergy and Mast Cell Activation Disorder.


Declaration

Dr Suranjith Seneviratne has indicated that they do not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Suranjith Seneviratne has indicated that they do not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Suranjith Seneviratne has indicated that they do not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.